PhRMA Must Tackle Cost-Effectiveness “Dilemma,” J&J’s Weldon Says

The Pharmaceutical Research & Manufacturers of America is considering the development of principles on evidence-based medicine to help it engage more directly in the debate over the cost-effectiveness of medicines